Open AccessSeverity of the Toxicity Associated With Combinations That Include Didanosine Plus Stavudine in HIV-Infected Experienced Patients
Author(s) -
Beatríz Hernández,
Santiago Moreno,
María Jesús Pérez-Elías,
José L. Casado,
Fernando Dronda,
Ana Moreno,
Antonio Antela
Publication year - 2006
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/01.qai.0000245881.20768.95
Subject(s) - didanosine , stavudine , medicine , toxicity , human immunodeficiency virus (hiv) , mitochondrial toxicity , sida , virology , viral disease , zidovudine
The combination of didanosine (ddI) and stavudine (d4T) is no longer recommended as a first-line treatment because of toxicity, but it may be useful in experienced patients.